BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
BHVN
Delisted
BHVN was delisted on the 3rd of October, 2022.
222 hedge funds and large institutions have $5.7B invested in Biohaven Pharmaceutical Holding Company Ltd. in 2021 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 93 increasing their positions, 67 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
1% less funds holding
Funds holding: 224 → 222 (-2)
3% less first-time investments, than exits
New positions opened: 38 | Existing positions closed: 39
Holders
222
Holding in Top 10
14
Calls
$92.9M
Puts
$79.8M
Top Buyers
| 1 | +$128M | |
| 2 | +$89.3M | |
| 3 | +$88.2M | |
| 4 |
AG
Artal Group
Luxembourg
|
+$38.8M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$28.7M |
Top Sellers
| 1 | -$149M | |
| 2 | -$97.1M | |
| 3 | -$48.5M | |
| 4 |
KCM
Kingdon Capital Management
New York
|
-$44.6M |
| 5 |
EP
Eversept Partners
New York
|
-$16.6M |